Denna sida på svenska
Loading profile information...

About me

2017-present:  Associate Professor at Karolinska Institutet, MTC

2008-2017: Group Leader at Ludwig Institute for Cancer Research 

2006-2008: Instructor of Medicine, Dana-Farber Cancer Institute/Harvard Medical School, Boston, USA

2003-2006: Postdoctoral Fellow, Dana-Farber Cancer Institute/Harvard Medical School, Boston, USA



2002: PhD, Duke University Medical School, Durham, N.C., USA, 2002

1999: MSc, Humboldt University, Berlin, Germany

Research description

Our research concerns the mechanisms of how disruption of oxygen-sensing pathways can lead to cancer. Oxygen sensors enable the cell to adapt to low-oxygen environments and are critical for normal development and apoptosis. These events are often disrupted in the development of tumors. Oxygen sensing is mediated partly via prolyl hydroxylases that require molecular oxygen for enzymatic activity. Our work focuses on how prolyl hydroxylases execute apoptosis in neural precursors during development and how disruption of this process can lead to certain forms of nervous-system tumors.

Loading publication list...